UNH's dip to $250 offers a strong buy opportunity with solid revenue growth, resilient dividends, and historic low P/E.

Below is Validea's guru fundamental report for UNITEDHEALTH GROUP INC (UNH). Of the 22 guru strategies ... underlying fundamentals and the stock’s valuation. A score of 80% or above typically ...

Below is Validea's guru fundamental report for UNITEDHEALTH GROUP INC (UNH). Of the 22 guru strategies ... underlying fundamentals and the stock’s valuation. A score of 80% or above typically ...

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum ...

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...

UnitedHealth Group (UNH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

UnitedHealth (UNH) stock is surging after its CEO bought $25 million in stock, even as the company faces legal and leadership ...

S&P 500, Northern Trust Corporation, Unitedhealth Group, Hims Hers Health Inc. Read 's Market Analysis on Investing.com ...

UnitedHealth's strategy of providing medical insurance, pharmacy benefits, and healthcare services should create a powerful alignment of incentives to help clients control their healthcare costs ...

Based on InvestingPro’s Fair Value analysis, the stock appears to be trading above its intrinsic value. Investors can find more detailed valuation metrics and additional insights through ...

UnitedHealth (UHS) shares have crashed in recent weeks amidst a tirade of bad news, including allegations that it made bonus ...

On May 19, TD Cowen revised its rating on UnitedHealth Group (NYSE:UNH), downgrading it to Hold from Buy and lowered the price target to $308 from $520. The downgrade is attributed to the ...